Did the "compassionate use" for multi level candidates happen in the beginning or middle of the fda trials? And how did that get initiated? When using the term "off label" I think of AFTER FDA approval, not during the trial. Can you clarify.
__________________
Injured 9/01
Annular tears L4/5 & L5/S1
denied adr by insurance for 2 level charite as well as hybrid fusion at L5/S1 with Charite at L4/5.
New ins paid for 2 level lumbar prodisc surgery on 4/7/08 (at age 39) with Dr. Westerlund, at Core Orthop
|